| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0005249 | Voltage-gated potassium channel activity | Increases phenotype | PMID:29183753 |
| GO:0005980 | Glycogen catabolic process | Increases phenotype | PMID:2982682 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:10642304 |
| GO:0006694 | Steroid biosynthetic process | Affects phenotype | PMID:34896276 |
| GO:0006701 | Progesterone biosynthetic process | Increases phenotype | PMID:24740604 |
| GO:0006702 | Androgen biosynthetic process | Increases phenotype | PMID:27388148; PMID:31184881; PMID:31184881; PMID:31499053; PMID:31499053; PMID:33862173 |
| GO:0006936 | Muscle contraction | Increases phenotype | PMID:39151807 |
| GO:0006949 | Syncytium formation | Increases phenotype | PMID:32028606 |
| GO:0007268 | Chemical synaptic transmission | Increases phenotype | PMID:15813995 |
| GO:0008209 | Androgen metabolic process | Affects phenotype | PMID:27148549; PMID:32898603 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:11802967 |
| GO:0010893 | Positive regulation of steroid biosynthetic process | Increases phenotype | PMID:29560447 |
| GO:0015562 | Efflux transmembrane transporter activity | Decreases phenotype | PMID:30610963 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:11517154; PMID:16077714; PMID:18328801 |
| GO:0030154 | Cell differentiation | Increases phenotype | PMID:16997883 |
| GO:0032310 | Prostaglandin secretion | Increases phenotype | PMID:26945481 |
| GO:0033327 | Leydig cell differentiation | Increases phenotype | PMID:22927073 |
| GO:0033344 | Cholesterol efflux | Increases phenotype | PMID:17478430 |
| GO:0035935 | Androgen secretion | Increases phenotype | PMID:33581290 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:7586449 |
| GO:0042701 | Progesterone secretion | Increases phenotype | PMID:31132478 |
| GO:0046697 | Decidualization | Increases phenotype | PMID:26945481 |
| GO:0046982 | Protein heterodimerization activity | Decreases phenotype | PMID:29669941 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:27388148 |
| GO:0140115 | Export across plasma membrane | Decreases phenotype | PMID:30610963 |
| GO:2000836 | Positive regulation of androgen secretion | Increases phenotype | PMID:37419161; PMID:37419161; PMID:37783241; PMID:37783241 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.